CureVac competitorsClear all

CureVac's top competitors include Stemirna, RNACure, RNAimmune, Moderna, Regulus Therapeutics and Sarepta Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
CureVac
CureVac
CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.
Stemirna
Stemirna
Stemirna is an RNA technology-based drug development company.
RNACure
RNACure
RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.
RNAimmune
RNAimmune
RNAimmune is a company specializing in the field of messenger RNA (mRNA) technology.
Moderna
Moderna
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Founding Date
Founding Date
2000
Founding Date
2016
Founding Date
2019
Founding Date
N/A
Founding Date
N/A
Founding Date
2007
Founding Date
1980
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
Tübingen, DE
Boston, US
Locations
Shanghai, CN HQ
Locations
Shanghai, CN HQ
Locations
Gaithersburg, US HQ
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Norwood, US
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Boulogne Billancourt, FR
Berlin, DE
Dublin, IE
Milano, IT
Chiyoda City, JP
see more
Employees
Employees
4004% increase
Employees
N/A
Employees
5
Employees
N/A
Employees
8309% increase
Employees
2462% decrease
Employees
74349% increase
Valuation ($)
Valuation ($)
1.5 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
91.6 b
Valuation ($)
36.5 m
Valuation ($)
7.5 b
Twitter followers
Twitter followers
6
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
137 k
Twitter followers
813
Twitter followers
3.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
67
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
16
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
116.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
9.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
87.5%
Alexa Website Rank
Alexa Website Rank
210991
Alexa Website Rank
189452
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
67329
Alexa Website Rank
393437
Alexa Website Rank
181719
Employee Rating
Employee Rating
4.2
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4
Employee Rating
2.8
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
€12.6m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$803.4m (FY, 2020)
Revenue (est.)
$10m (FY, 2020)
Revenue (est.)
$540.1m (FY, 2020)
Cost of goods
Cost of goods
€22.3m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$7.9m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
(€9.8m) (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$795.5m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
(€74.6m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($747.1m) (FY, 2020)
Net income
($15.7m) (FY, 2020)
Net income
($554.1m) (FY, 2020)

Operating

Patent Applications
Patent Applications
500 (Mar, 2020)
Patent Applications
2 (May, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
250 (May, 2017)
Patent Applications
N/A
Patent Applications
N/A
Patents Issued
Patents Issued
233 (May, 2020)
Patents Issued
2 (May, 2020)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
100 (Q3, 2018)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Platforms
Platforms
N/A
Platforms
3 (May, 2020)
Platforms
2 (May, 2020)
Platforms
N/A
Platforms
N/A
Platforms
N/A
Platforms
N/A

Funding

Latest funding round
Latest funding round
$ 640m (over 1 year ago)
Latest funding round
$ 188m (6 months ago)
Latest funding round
N/A
Latest funding round
$ 10m (7 months ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 1.1b
Total funding raised
$ 206.5m
Total funding raised
N/A
Total funding raised
$ 12.4m
Total funding raised
$ 1.8b
Total funding raised
$ 10m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Stemirna
HQ
Shanghai, CN

Stemirna is an RNA technology-based drug development company.

View company
RNACure
HQ
Shanghai, CN
Employees
5

RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.

View company
RNAimmune
HQ
Gaithersburg, US

RNAimmune is a company specializing in the field of messenger RNA (mRNA) technology.

View company
Moderna
HQ
Cambridge, US
Employees
830↑ 9% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company